Stefan Loren's Net Worth

-$12 Thousand

Estimate Recalculated Feb 7, 2024 03:47PM EST

Who is Stefan Loren?

Stefan Loren does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Marina Biotech, Inc., POLYMEDIX, INC, Cellectar Biosciences, Inc., GENVEC INC, and ORCHID CELLMARK INC.

SEC CIK

Stefan Loren's CIK is 0001441500

Past Insider Trading and Trends

2014 was Stefan Loren's most active year for acquiring shares with 7 total transactions. Stefan Loren's most active month to acquire stocks was the month of October. 2017 was Stefan Loren's most active year for disposing of shares, totalling 2 transactions. Stefan Loren's most active month to dispose stocks was the month of May. 2015 saw Stefan Loren paying a total of $7,715.62 for 57,000 shares, this is the most they've acquired in one year. In 2016 Stefan Loren cashed out on 793 shares for a total of $5,701.67, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Marina Biotech, Inc. (ATRX) No price found

Investor

Stefan Loren owns 181,303 units of Common Stock. From 2012 to 2017 Stefan Loren acquired a total of 181,303 shares in Marina Biotech, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jan 6
Form 4
—
0
—
—
0
Sep 15
Form 4
∞
181.3K
—
—
181.3K
Jan 1
Form 3
—
0
—
—
0
No matching records found

POLYMEDIX, INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 26
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Sep 2
Form 4
—
0
—
—
0
Sep 23
Form 4
—
0
—
—
0
Jul 31
Form 3
—
0
—
—
0
No matching records found

Cellectar Biosciences, Inc. (CLRB) Snapshot price: $3.58

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Oct 12
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jul 5
Form 3
—
0
—
—
0
No matching records found

GENVEC INC No price found

Investor

Stefan Loren used to own units in Common Stock but no longer holds any shares there. From 2013 to 2017 Stefan Loren acquired a total of 7,500 shares in GENVEC INC at a cost of $17,715.62, Stefan also disposed a total of 2,000 shares of GENVEC INC equalling to $5,701.67.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-500.00
$5.50
$5,700.00
0
Jun 16 - Jun 16
Form 4
—
0
—
—
0
Oct 20
Form 4
+400.00%
4K
$1.93
$7,715.62
5K
Nov 16
Form 4
—
0
—
—
0
Nov 13
Form 4/A
∞
1K
$2.15
$2,150.00
1K
Dec 31
Form 4
∞
1K
$2.15
$2,150.00
1K
Dec 31
Form 4
—
0
—
—
0
Dec 5
Form 4
—
0
—
—
0
Nov 22
Form 4
—
0
—
—
0
Sep 19
Form 3
—
0
—
—
0
No matching records found

ORCHID CELLMARK INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found